Sun Pharmaceutical Industries said that it was granted an approval by US FDA for its Abbreviated New Drug Application (ANDA) to market a generic version of Schering Plough's Clarinex tablets of 5 mg strength.
These tablets contain Desloratadine 5 mg and are therapeutically equivalent to Schering Plough's Clarinex tablets. These are indicated in the treatment of seasonal allergic rhinitis, perennial allergic rhinitis and chronic idiopathic urticaria. These tablets have annual sales of $212 million in US.
For comments and feedback contact: editorial@rttnews.com
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.